"Om Megashree Pharmaceuticals IPO Allotment Scheduled for 12th Chaitra – Nearly 20 Lakh Applicants Compete for Shares!"
The IPO allotment for Om Megashree Pharmaceuticals Limited is scheduled for this Tuesday, 12th Chaitra, 2081. The allotment event will take place at Prabhu Capital Limited, Lazimpat, which is the issue manager for this offering.
The company had a total issued capital of Rs. 60 crore, out of which 30%—equivalent to 18,00,000 unit shares worth Rs. 18 crore—was made available to the public. From this, 10% (1,80,000 units) had already been allocated to Nepalese citizens working abroad. Additionally, 5% (90,000 units) was reserved for mutual funds, while 3% (54,000 units) was set aside for the company’s employees. The remaining 14,76,000 shares were up for grabs by the general public at a face value of Rs. 100 per share.
According to CDSC, a total of 19,88,836 applicants submitted applications for 2,36,91,510 shares, amounting to Rs. 2.36 Arba by the closing date. Given this overwhelming demand, only 1,47,600 lucky applicants will secure shares in the company.
In terms of financial ratings, CARE Ratings Nepal Limited (CRNL) has reaffirmed a ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited, indicating a moderate default risk. The company also holds a ‘CARE-NP BB-’ rating for its long-term bank facilities and a ‘CARE-NP A4’ rating for its short-term bank facilities.
Founded on June 12, 2016, Om Megashree Pharmaceuticals Limited is a public limited company in Nepal, backed by institutional and individual investors. The company operates a pharmaceutical manufacturing facility in Chitwan and began partial production on February 19, 2024.
